Navigation Links
Statement from ASH President Armand Keating, M.D., on FDA action to alleviate drug shortages
Date:2/21/2012

(WASHINGTON, February 21, 2012) The American Society of Hematology (ASH) is encouraged by the steps FDA is taking to alleviate drug shortages that have significantly affected so many patients with hematologic malignancies under our members' care. The measures announced today are consistent with the Society's recommendations to FDA, Congress, and the Obama Administration to expand the agency's authority to prevent drug shortages by requiring manufacturers to provide early notification of impending shortages and importing drugs in critical supply.

While ASH applauds the specific actions announced today, we also realize that these measures represent only a portion of a solution to a much larger problem. In addition to these steps, additional measures - such as developing a national drug registry and providing economic incentives to manufacturers to produce a steady supply of generics - must be implemented to permanently prevent shortages. Until a complete solution is in place, treatment will be delayed and care will be rationed for critically ill patients. ASH will continue to support legislative, regulatory, and policy changes that will give FDA the ability to prevent and mitigate drug shortages before they progress to crisis status.


'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
202-552-4927
American Society of Hematology
Source:Eurekalert

Page: 1

Related medicine news :

1. American Society of Hematology statement on critical methotrexate drug shortage
2. ATS issues joint statement on key issues and recommendations for critical care research
3. ACR and SBI issue statement on British Medical Journal article on effect of mammography on breast cancer death rates
4. EMAS publishes position statement about the post-reproductive health of women
5. AMP releases statement on diagnostics in drug labels
6. Radiation risks to health: A joint statement from leading scientific experts
7. ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis
8. ATS issues statement on the treatment of pulmonary fungal infections
9. IOF statement on new IOM dietary reference intakes for calcium and vitamin D
10. EMAS publishes position statements about the post-reproductive health of women
11. AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
(Date:10/12/2017)... ... 12, 2017 , ... Vohra Chief Medical Officer Dr. Shark ... skilled nursing facility medical directors and other clinicians at various events in October. ... "At many of these conferences we get to educate other physicians, facility nurses, ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
Breaking Medicine Technology: